ERBB2 and neoplasm: Biopsy of the lesion revealed a well-differentiated tubular adenocarcinoma (Figure 2(a)), and HER2 immunohistochemistry (IHC) scoring of the tumor in the biopsy specimen was 3+, indicating HER2-positivity (Figure 2(b)).